EP 1381360 A1 20040121 - COMPOUNDS AND METHODS FOR INHIBITING METAP2 IN MAMMALS
Title (en)
COMPOUNDS AND METHODS FOR INHIBITING METAP2 IN MAMMALS
Title (de)
Verbindungen und Verfahren zur Hemmung von MetAP2 in Säugern
Title (fr)
COMPOSES ET PROCEDES POUR INHIBER LA METAP2 CHEZ LES MAMMIFERES
Publication
Application
Priority
- US 0209954 W 20020328
- US 27956301 P 20010329
Abstract (en)
[origin: WO02078697A1] Compounds of this invention are non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, useful in treating conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis, ocular neovascularization and obesity.
IPC 1-7
IPC 8 full level
A61K 31/41 (2006.01); A61K 31/00 (2006.01); A61K 31/381 (2006.01); A61K 31/4196 (2006.01); A61K 31/4439 (2006.01); A61K 31/4709 (2006.01); A61P 3/04 (2006.01); A61P 9/10 (2006.01); A61P 17/06 (2006.01); A61P 19/02 (2006.01); A61P 27/02 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01); C07C 335/38 (2006.01); C07D 249/14 (2006.01); C07D 333/22 (2006.01); C07D 333/24 (2006.01); C07D 401/04 (2006.01); C07D 401/12 (2006.01); C07D 409/06 (2006.01); C07D 409/12 (2006.01)
CPC (source: EP)
A61K 31/00 (2013.01); A61K 31/4196 (2013.01); A61K 31/4439 (2013.01); A61K 31/4709 (2013.01); A61P 3/04 (2017.12); A61P 9/10 (2017.12); A61P 17/06 (2017.12); A61P 19/02 (2017.12); A61P 27/02 (2017.12); A61P 29/00 (2017.12); A61P 35/00 (2017.12); C07C 335/38 (2013.01); C07D 249/14 (2013.01); C07D 333/24 (2013.01); C07D 401/04 (2013.01); C07D 409/06 (2013.01); C07D 409/12 (2013.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 02078697 A1 20021010; EP 1381360 A1 20040121; EP 1381360 A4 20091202; JP 2005508841 A 20050407
DOCDB simple family (application)
US 0209954 W 20020328; EP 02723701 A 20020328; JP 2002576963 A 20020328